	Diagnosis, clinical assessment, and staging of hepatocellular carcinoma: a Brazilian multidisciplinary consensus. Arq Bras Cir Dig Coimbra FJF, Godoy AL, Fernandes PHS, Feitosa Neto H, Pinheiro RN, Boin IFSF, Andraus W, Tustumi F, Amaral PCGD, Brandão Mello CE, Braun AC, Braghiroli MI, Bredt LC, Caparroz C, Carrilho FJ, Cunha GM, Diniz AL, Forte DN, Garcia JHP, Genzini T, Correia MM, Oliveira CVC, Kalil AN, Lima AS, Martins GLP, Rocha CM, Menezes MR, Motta-Leal-Filho JMD, Murad Júnior M, Peixoto RD, Pinheiro RS, Rezende MB, Ribeiro HSC, Martins MR, Rocha Filho DRD, Rosa AA, Szutan LA, Torres OJM, Carneiro D'Albuquerque LA, Mattos ÂA, Coutinho AK, Herman P, Oliveira AF. PMID: 42690308 [PubMed - indexed for MEDLINE]
	Evaluation of inter-fractional anatomical variations due to compression belt placement reproducibility using MR-guided radiotherapy treatment fraction images. J Appl Clin Med Phys Shay O, Solis D, Aire M, Schneider C, Kirby K. PMID: 42690096 [PubMed - indexed for MEDLINE]
	Integrated multi-omics analysis of metabolomics and proteomics uncovers dysregulated amino acid metabolism in HCC metastasis. Front Immunol Wu J, Wang J, Yu Z, Yang R. PMID: 42688489 [PubMed - indexed for MEDLINE]
	Mitochondrial Quality Regulation Genes as Prognostic Markers in Hepatocellular Carcinoma: Tumor Microenvironment, Therapeutic Response, and Drug Sensitivity Analysis. Drug Dev Res Li B, Zeng L, He Z, Luo L, Luo Y, Yi X, Li Z, Zhu H, Li Y. PMID: 42687711 [PubMed - indexed for MEDLINE]
	Neutrophil extracellular traps in colorectal cancer: context-dependent roles from inflammatory carcinogenesis to liver metastasis and therapeutic targeting. J Transl Med Xu D, Wang R, Tan J. PMID: 42687197 [PubMed - indexed for MEDLINE]
	Precision Oncology in Hepatopancreatobiliary Cancer Surgery. Hematol Oncol Clin North Am Newhook TE, Tsai S, Meric-Bernstam F. PMID: 42686331 [PubMed - indexed for MEDLINE]
	Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma. Korean J Radiol Huang PH, Ou HY, Tsang LC, Hsu HW, Lim WX, Huang TL, Weng CC, Lu Y, Hsu CC, Chen CL, Yu CY, Cheng YF. PMID: 42683641 [PubMed - indexed for MEDLINE]
	Liver microenvironment-driven immunosuppressive niche in colorectal cancer liver metastasis and its therapeutic remodeling. Front Immunol Liu Z, Liu J, Xu S, Zhong Y, He KJ, Lu Z, Zheng Y, Zhang Y, Guo Q, Chu H. PMID: 42683268 [PubMed - indexed for MEDLINE]
	The association between sarcopenia and the prognosis of patients with high tumor burden hepatocellular carcinoma receiving hepatic artery infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitor: a multicenter, propensity score matching comparative study. Front Immunol Li X, Dong Y, Chen W, Wang Y, Sun P, Chang X, Wu C, Wang D. PMID: 42682768 [PubMed - indexed for MEDLINE]
	Association between gut microbiota characteristics and therapeutic efficacy of multimodal combination therapy in hepatocellular carcinoma with portal vein tumor thrombus: a secondary analysis of a prospective phase II trial. Front Immunol Liang X, Li Y, Liang M, Zeng Z, Hu K, Yang L, Yan H, Li M, Zeng J, Tang J, Lv Y, Liang L, Meng J, Su H, Ma J, Mo N. PMID: 42682622 [PubMed - indexed for MEDLINE]
	Integrative Multi-Omics Mendelian Randomization Analysis Identifies NIT2 as a Potential Metabolic Risk Gene in Hepatocellular Carcinoma. J Gene Med Liao Z, Fang Q, Chen Y, Yang X, Wu H, Wang H, Gao J. PMID: 42681890 [PubMed - indexed for MEDLINE]
	Focal nodular hyperplasia: a rare benign liver tumour in early childhood without predisposing factors. BMJ Case Rep Agarwal N, Kumar T, Mathew P, Kumar B. PMID: 42680507 [PubMed - indexed for MEDLINE]
	Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for (90)Y Radioembolization with Immunotherapy in HCC. Radiology Avritscher R, Kim E, Chew V, Abou-Alfa GK, Kaseb A, Toskich B, Gade T, Mendiratta-Lala M, Krishnan S, Kappadath SC, Salem R. PMID: 42678260 [PubMed - indexed for MEDLINE]
	Measuring quality of life in advanced chronic liver disease with FACT-Hep: Findings from the PAL LIVER trial. Hepatol Commun Verma M, John BV, Rockey D, Barritt S, Navarro V, Shaw LK, Kosinski A, Tapper EB, Desai A. PMID: 42678241 [PubMed - indexed for MEDLINE]
	Roles of exosome-mediated macrophage polarization in the hepatocellular carcinoma progression. Front Immunol Chen A, Zhu M. PMID: 42676581 [PubMed - indexed for MEDLINE]
	Prognostic Impact of Arterial Phase Hyperenhancement After Proton Beam Therapy for Untreated Solitary Hepatocellular Carcinoma. Cancer Med Niitsu H, Mizumoto M, Li Y, Harada M, Sawada T, Goto M, Sumiya T, Baba K, Fujisawa T, Nakamura M, Ishida T, Iizumi T, Saito T, Numajiri H, Nakai K, Oshiro Y, Sakurai H. PMID: 42675808 [PubMed - indexed for MEDLINE]
	Antiproteinuric Effect of SGLT2 Inhibitors in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Anticancer Res Hori T, Yamamoto K, Aoi H, Koizumi Y, Kuromatsu M, Fukui A, Okamoto H, Hirata A, Shinmori K, Imanaka Y, Namba M, Kitamura S, Nakanishi K, Tsushima H, Yano I, Moriya K, Matsui M, Ikushima S. PMID: 42674726 [PubMed - indexed for MEDLINE]
	MMP-2 rs243865 Polymorphism as a Risk Modifier of Hepatocellular Carcinoma in Taiwanese Males, Smokers and Alcohol Consumers. Anticancer Res Yueh TC, Wu MH, Yang MD, Lu MC, Shao YC, Ke TW, Wang ZH, Chen CA, Tsai CW, Bau DT, Chang WS. PMID: 42674711 [PubMed - indexed for MEDLINE]
	Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma. Anticancer Res Kuwano A, Yada M, Tanaka K, Hamamoto T, Tanaka R, Kurosaka K, Suzuki H, Motomura K. PMID: 42674706 [PubMed - indexed for MEDLINE]
	Impact of Cirrhosis Outcome Risk Estimator (CORE) Risk Score on Prognosis Following Hepatectomy for Hepatocellular Carcinoma. Anticancer Res Takagi K, Nishiyama T, Kimura J, Fuji T, Yasui K, Fujiwara T. PMID: 42674693 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77352

Page 1 of 3868



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy